Cepheid (CPHD) - Product Pipeline Analysis

Document Sample
Cepheid (CPHD)  - Product Pipeline Analysis Powered By Docstoc
					                                             Cepheid (CPHD) - Product Pipeline Analysis

     Reference Code: GDMEPH7437PD                                                                                          Publication Date: NOV 2010



     Company Snapshot                                                     Company Overview
     Key Information
                                                                          Cepheid is a molecular diagnostic company engaged in the development,
     Cepheid, Key Facts                                                   manufacture and marketing of fully-integrated systems and tests for genetic
                                                                          analysis in the clinical, industrial and biothreat markets. These systems
     Web Address                            www.cepheid.com
                                                                          allow rapid and sophisticated genetic testing of organisms and genetic-
     Turnover (in USD Million)              170.60                        based diseases. The company's two major systems include the
                                                                          SmartCycler and GeneXpert systems. Cepheid’s operations are spread
     Number of Employees                    547                           across North America, Europe, and Japan. The company is headquartered
     Industry                               Pharmaceuticals and           in California, the US. The company received clearance from the US FDA to
                                            Healthcare-                   market Xpert vanA, the resistant gene most associated with hospital
     Source:Primary / Secondary Research                                  acquired VRE infections.
     GlobalData




     Cepheid Pipeline Products

     Cepheid Key Pipeline Products by Equipment Type                      Cepheid Key Pipeline Products by Therapy Area

     Equipment Type                                      No of Products   Therapy Area                                           No of Products
     Infectious Immunology                                     26         Bladder cancer                                                3
     Immuno Chemistry                                             4       Hepatitis C infection                                         2
     Genetic Testing                                              2       Herpes simplex virus infection                                2
     Source: Primary / Secondary Research                                 Hospital acquired infections                                  2
     GlobalData
                                                                          Chlamydia                                                     1
                                                                          Chlamydia trachomatis infection, Neisseria                    1
                                                                          gonorrhoeae infection
                                                                          Chronic myelogenous leukemia                                  1
                                                                          Source: Primary / Secondary Research
                                                                          GlobalData


     Cepheid Key Pipeline Products by Equipment Type




     Source: Primary / Secondary Research
     GlobalData




     Cepheid Key Pipeline Products by Development Stage                   Cepheid Key Pipeline Products by Trial Phase

     Developmental Stage                             No of Products       Trial Phase                                    No of Products
     Clinicals                                              7             Phase IV                                               -
     Pre-Clinicals                                                        Phase III                                              -
                                                             -
     Early development                                      22            Phase II                                               -
     Source: Primary / Secondary Research                                 Phase I                                                -
     GlobalData
                                                                          Source: Primary / Secondary Research
     Note : (-) indicates 'Not Available'
                                                                          GlobalData
                                                                          Note : (-) indicates 'Not Available'




Cepheid (CPHD) - Product Pipeline Analysis                                                                                   Reference Code: GDMEPH7437PD

Source : www.globalcompanyintelligence.com                                                                                                              Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 5
     List of Figures......................................................................................................................................................................................................................................................................... 7
     Cepheid - Business Description ............................................................................................................................................................................................................................................. 8
     Key Facts ............................................................................................................................................................................................................................................................................... 8
     Cepheid - Major Products and Services................................................................................................................................................................................................................................. 9
           Cepheid Pipeline Products by Equipment Type ............................................................................................................................................................................................................ 10
           Cepheid Pipeline Products by Development Stage ....................................................................................................................................................................................................... 12
           Cepheid Pipeline Products by Therapy Area................................................................................................................................................................................................................. 14
           Cepheid Pipeline Products by Milestone Summary....................................................................................................................................................................................................... 17
           CT/NG Test.................................................................................................................................................................................................................................................................... 19
                 Product Status......................................................................................................................................................................................................................................................... 19
                 Product Description ................................................................................................................................................................................................................................................. 19
           Flu A/B Panel Test......................................................................................................................................................................................................................................................... 19
                 Product Status......................................................................................................................................................................................................................................................... 19
                 Product Description ................................................................................................................................................................................................................................................. 19
           Gastro Panel test ........................................................................................................................................................................................................................................................... 20
                 Product Status......................................................................................................................................................................................................................................................... 20
                 Product Description ................................................................................................................................................................................................................................................. 20
           GeneXpert MTB/RIF Assay ........................................................................................................................................................................................................................................... 20
                 Product Status......................................................................................................................................................................................................................................................... 20
                 Product Description ................................................................................................................................................................................................................................................. 20
                 Product Milestone ................................................................................................................................................................................................................................................... 20
           Group A Strep assay ..................................................................................................................................................................................................................................................... 21
                 Product Status......................................................................................................................................................................................................................................................... 21
                 Product Description ................................................................................................................................................................................................................................................. 21
           HPV assay ..................................................................................................................................................................................................................................................................... 21
                 Product Status......................................................................................................................................................................................................................................................... 21
                 Product Description ................................................................................................................................................................................................................................................. 22
           HSV lesion test .............................................................................................................................................................................................................................................................. 22
                 Product Status......................................................................................................................................................................................................................................................... 22
                 Product Description ................................................................................................................................................................................................................................................. 22
           MRSA/SA SSTI (CW) test ............................................................................................................................................................................................................................................. 22
                 Product Status......................................................................................................................................................................................................................................................... 22
                 Product Description ................................................................................................................................................................................................................................................. 23
           Mycology Panel assay ................................................................................................................................................................................................................................................... 23
                 Product Status......................................................................................................................................................................................................................................................... 23
                 Product Description ................................................................................................................................................................................................................................................. 23
           Noro virus test................................................................................................................................................................................................................................................................ 23
                 Product Status......................................................................................................................................................................................................................................................... 23
                 Product Description ................................................................................................................................................................................................................................................. 23
           Sepsis Fungal Test ........................................................................................................................................................................................................................................................ 24
                 Product Status......................................................................................................................................................................................................................................................... 24
                 Product Description ................................................................................................................................................................................................................................................. 24
           Sepsis tests ................................................................................................................................................................................................................................................................... 24
                 Product Status......................................................................................................................................................................................................................................................... 24
                 Product Description ................................................................................................................................................................................................................................................. 24
           Vaginitis Panel assay..................................................................................................................................................................................................................................................... 24
                 Product Status......................................................................................................................................................................................................................................................... 24
                 Product Description ................................................................................................................................................................................................................................................. 25
           Xpert BCR-ABL Monitor Test......................................................................................................................................................................................................................................... 25
                 Product Status......................................................................................................................................................................................................................................................... 25
                 Product Description ................................................................................................................................................................................................................................................. 25
                 Product Milestone ................................................................................................................................................................................................................................................... 26
                 Xpert BCR-ABL Monitor Test Clinical Trial ............................................................................................................................................................................................................. 26
           Xpert C. difficile/Epi ....................................................................................................................................................................................................................................................... 27
                 Product Status......................................................................................................................................................................................................................................................... 27
                 Product Description ................................................................................................................................................................................................................................................. 27
           Xpert MRSA Next Generation Assay............................................................................................................................................................................................................................. 27
                 Product Status......................................................................................................................................................................................................................................................... 27

Cepheid (CPHD) - Product Pipeline Analysis                                                                                                                                                                                                        Reference Code: GDMEPH7437PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                     Page 2
                 Product Description ................................................................................................................................................................................................................................................. 28
           Xpert MRSA/SA Nasal test ............................................................................................................................................................................................................................................ 28
                 Product Status......................................................................................................................................................................................................................................................... 28
                 Product Description ................................................................................................................................................................................................................................................. 28
                 Product Milestone ................................................................................................................................................................................................................................................... 28
                 Product Patent Details ............................................................................................................................................................................................................................................ 29
           Xpert.2C19 Assay.......................................................................................................................................................................................................................................................... 30
                 Product Status......................................................................................................................................................................................................................................................... 30
                 Product Description ................................................................................................................................................................................................................................................. 30
           Xpert.Bladder Cancer Asymptomatic Assay.................................................................................................................................................................................................................. 30
                 Product Status......................................................................................................................................................................................................................................................... 30
                 Product Description ................................................................................................................................................................................................................................................. 30
           Xpert.Bladder Cancer Monitor/Recurrence Test............................................................................................................................................................................................................ 31
                 Product Status......................................................................................................................................................................................................................................................... 31
                 Product Description ................................................................................................................................................................................................................................................. 31
           Xpert.Bladder Cancer Symptomatic Assay.................................................................................................................................................................................................................... 31
                 Product Status......................................................................................................................................................................................................................................................... 31
                 Product Description ................................................................................................................................................................................................................................................. 31
           Xpert.CMV Quant Assay................................................................................................................................................................................................................................................ 32
                 Product Status......................................................................................................................................................................................................................................................... 32
                 Product Description ................................................................................................................................................................................................................................................. 32
           Xpert.CT/NG FluroQ Resistant Assay ........................................................................................................................................................................................................................... 32
                 Product Status......................................................................................................................................................................................................................................................... 32
                 Product Description ................................................................................................................................................................................................................................................. 32
           Xpert.EBV Quant Assay ................................................................................................................................................................................................................................................ 33
                 Product Status......................................................................................................................................................................................................................................................... 33
                 Product Description ................................................................................................................................................................................................................................................. 33
           Xpert.HBV Quant Assay ................................................................................................................................................................................................................................................ 33
                 Product Status......................................................................................................................................................................................................................................................... 33
                 Product Description ................................................................................................................................................................................................................................................. 33
           Xpert.HCV Genotype Assay .......................................................................................................................................................................................................................................... 33
                 Product Status......................................................................................................................................................................................................................................................... 33
                 Product Description ................................................................................................................................................................................................................................................. 34
           Xpert.HCV Quant Assay ................................................................................................................................................................................................................................................ 34
                 Product Status......................................................................................................................................................................................................................................................... 34
                 Product Description ................................................................................................................................................................................................................................................. 34
           Xpert.HIV Quant Assay.................................................................................................................................................................................................................................................. 34
                 Product Status......................................................................................................................................................................................................................................................... 34
                 Product Description ................................................................................................................................................................................................................................................. 35
           Xpert.HSV CSF Assay......................
				
DOCUMENT INFO
Description: Cepheid (CPHD) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Cepheid portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to Buy - Develop
BUY THIS DOCUMENT NOW PRICE: $750 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.